[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2191175T3 - Procedimiento para la captacion del estado de un organismo por medicion de peptidos. - Google Patents

Procedimiento para la captacion del estado de un organismo por medicion de peptidos.

Info

Publication number
ES2191175T3
ES2191175T3 ES97918977T ES97918977T ES2191175T3 ES 2191175 T3 ES2191175 T3 ES 2191175T3 ES 97918977 T ES97918977 T ES 97918977T ES 97918977 T ES97918977 T ES 97918977T ES 2191175 T3 ES2191175 T3 ES 2191175T3
Authority
ES
Spain
Prior art keywords
organism
capture
procedure
state
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97918977T
Other languages
English (en)
Inventor
Wolf-Georg Forssmann
Peter Schulz-Knappe
Michael Schrader
Hans-Georg Opitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovision AG
Original Assignee
Biovision AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26028345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2191175(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1996132521 external-priority patent/DE19632521A1/de
Application filed by Biovision AG filed Critical Biovision AG
Application granted granted Critical
Publication of ES2191175T3 publication Critical patent/ES2191175T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA DETERMINAR EL ESTADO DE UN ORGANISMO MEDIANTE LA MEDIDA DE PEPTIDOS PROCEDENTE DE UNA MUESTRA DEL ORGANISMO, QUE CONTIENE PEPTIDOS DE ELEVADO PESO MOLECULAR Y DE BAJO PESO MOLECULAR, COMO INDICADOR PARA EL ESTADO DEL ORGANISMO, DETECTANDOSE DIRECTAMENTE PEPTIDOS DE BAJO PESO MOLECULAR, Y SE CARACTERIZAN Y SE CORRELACIONAN CON UNA REFERENCIA.
ES97918977T 1996-08-13 1997-08-13 Procedimiento para la captacion del estado de un organismo por medicion de peptidos. Expired - Lifetime ES2191175T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1996132521 DE19632521A1 (de) 1996-08-13 1996-08-13 Verfahren zur Gewinnung von Peptiden aus Köperflüssigkeiten und Geweben sowie Zellüberständen und zur Identifikation von krankheitsrelevanten Peptidmarkern
DE19725362 1997-06-16

Publications (1)

Publication Number Publication Date
ES2191175T3 true ES2191175T3 (es) 2003-09-01

Family

ID=26028345

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97918977T Expired - Lifetime ES2191175T3 (es) 1996-08-13 1997-08-13 Procedimiento para la captacion del estado de un organismo por medicion de peptidos.

Country Status (16)

Country Link
US (1) US6875616B1 (es)
EP (1) EP0922226B2 (es)
JP (1) JP2001508864A (es)
CN (1) CN1233326A (es)
AT (1) ATE234469T1 (es)
AU (1) AU720626B2 (es)
CA (1) CA2263443C (es)
CZ (1) CZ294729B6 (es)
DE (1) DE59709517D1 (es)
DK (1) DK0922226T3 (es)
EA (1) EA001033B1 (es)
ES (1) ES2191175T3 (es)
IS (1) IS4971A (es)
PL (1) PL186810B1 (es)
PT (1) PT922226E (es)
WO (1) WO1998007036A1 (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
DE10021737C2 (de) * 2000-05-04 2002-10-17 Hermann Haller Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
US6756476B2 (en) 2001-04-30 2004-06-29 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons
US7087435B2 (en) 2001-04-30 2006-08-08 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
US7294688B2 (en) 2001-04-30 2007-11-13 Nanogen Inc. Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
US6617308B2 (en) 2001-04-30 2003-09-09 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons
US6620786B2 (en) 2001-04-30 2003-09-16 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having molecular weight of 2937 daltons
US6620787B2 (en) 2001-04-30 2003-09-16 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons
US6593298B2 (en) 2001-04-30 2003-07-15 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons
US6693080B2 (en) 2001-04-30 2004-02-17 Syn X Pharma Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons
US6602855B2 (en) 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
US6627606B2 (en) 2001-04-30 2003-09-30 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons
US7008800B2 (en) 2001-04-30 2006-03-07 Artemis Proteomics, Ltd. Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons
US7015004B2 (en) 2001-11-23 2006-03-21 Syn X Pharma, Inc. Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
US6890763B2 (en) 2001-04-30 2005-05-10 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons
US6703366B2 (en) 2001-04-30 2004-03-09 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons
US6627607B2 (en) 2001-04-30 2003-09-30 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons
US6677303B2 (en) 2001-04-30 2004-01-13 Syn X Pharma Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons
US7314717B2 (en) 2001-04-30 2008-01-01 Nanogen Inc. Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons
US6627608B2 (en) 2001-04-30 2003-09-30 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons
US20020160420A1 (en) * 2001-04-30 2002-10-31 George Jackowski Process for diagnosis of physiological conditions by characterization of proteomic materials
US6599877B2 (en) 2001-04-30 2003-07-29 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons
US20040198950A1 (en) 2001-04-30 2004-10-07 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons
US20020160533A1 (en) 2001-04-30 2002-10-31 George Jackowski Biopolymer marker indicative of disease state having a molecular of weight of 1525 daltons
DE10123711A1 (de) * 2001-05-15 2003-02-27 Wolfgang Altmeyer Verfahren zur Bestimmung der Herkunft biologischer Materialien
US7314762B2 (en) 2001-11-21 2008-01-01 Nanogen, Inc. Apolipoprotein biopolymer markers indicative of insulin resistance
US7132244B2 (en) 2001-11-21 2006-11-07 Syn X Pharma, Inc. Betaine/GABA transport protein biopolymer marker indicative of insulin resistance
US7179610B2 (en) 2001-11-23 2007-02-20 Nanogen Inc. Complement C3 precursor biopolymer markers indicative of insulin resistance
US20030100014A1 (en) * 2001-11-23 2003-05-29 George Jackowski Apolipoprotein biopolymer markers predictive of type II diabetes
US7026129B2 (en) 2001-11-23 2006-04-11 Syn X Pharma, Inc. IG lambda biopolymer markers predictive of Alzheimers disease
WO2003046556A2 (en) * 2001-11-23 2003-06-05 Syn.X Pharma, Inc. Globin biopolymer markers indicative of insulin resistance
US7122327B2 (en) 2001-11-23 2006-10-17 Nanogen Inc. Biopolymer markers indicative of type II diabetes
US7097989B2 (en) 2001-11-23 2006-08-29 Syn X Pharma, Inc. Complement C3 precursor biopolymer markers predictive of type II diabetes
US7125678B2 (en) 2001-11-23 2006-10-24 Nanogen, Inc. Protein biopolymer markers predictive of type II diabetes
US7179606B2 (en) 2001-11-23 2007-02-20 Syn X Pharma, Inc. IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease
US7052849B2 (en) 2001-11-23 2006-05-30 Syn X Pharma, Inc. Protein biopolymer markers predictive of insulin resistance
US7094549B2 (en) 2001-11-23 2006-08-22 Syn X Pharma, Inc. Fibronectin biopolymer marker indicative of insulin resistance
US7179605B2 (en) 2001-11-23 2007-02-20 Nanogen Inc. Fibronectin precursor biopolymer markers indicative of alzheimer's disease
US7135297B2 (en) 2001-11-23 2006-11-14 Nanogen Inc. Protein biopolymer markers indicative of insulin resistance
US6890722B2 (en) 2001-11-23 2005-05-10 Syn X Pharma, Inc. HP biopolymer markers predictive of insulin resistance
US7074576B2 (en) 2001-11-23 2006-07-11 Syn X Pharma, Inc. Protein biopolymer markers indicative of alzheimer's disease
US6906320B2 (en) 2003-04-02 2005-06-14 Merck & Co., Inc. Mass spectrometry data analysis techniques
DE10341193A1 (de) * 2003-09-06 2005-03-31 Mosaiques Diagnostics And Therapeutics Ag Vorrichtung und Verfahren zur quantitativen Auswertung der in einer Körperflüssigkeitsprobe enthaltenden Polypeptide sowie Marker zur Erkennung von pathologischen Zuständen
US20090035797A1 (en) * 2004-10-15 2009-02-05 Hancock William S Detection of Disease Associated Proteolysis
WO2009016431A1 (en) * 2007-08-01 2009-02-05 Digilab, Inc. Sample preparation method and apparatus
BRPI0920072A2 (pt) * 2008-10-31 2018-08-07 Bio Merieux Inc métodos para separação e caracterização de micro-organismos por agentes identificadores
JP5509213B2 (ja) * 2008-10-31 2014-06-04 ビオメリュー・インコーポレイテッド 質量分析を使用した微生物の分離、キャラクタリゼーションおよび／または同定方法
BRPI0920114B1 (pt) * 2008-10-31 2021-08-17 Biomerieux, Inc. Métodos para o isolamento e a identificação de micro-organismos
EP2831598B1 (en) * 2012-03-30 2017-07-26 BD Kiestra B.V. Automated selection of microorganisms and identification using maldi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5537944A (en) * 1978-09-09 1980-03-17 Seiichi Shibata Diagnosis chemical and diagnosis method of kidney disease
CA2140241A1 (en) * 1992-07-15 1994-02-03 Thomas N. Thomas Blood levels of cck peptides relative to panic disorder treatment
US5492834A (en) * 1993-07-09 1996-02-20 Beckman Instruments, Inc. Method of sample preparation for urine protein analysis with capillary electrophoresis
DE4427531A1 (de) * 1994-08-04 1996-02-08 Forssmann Wolf Georg Humanes zirkulierendes beta-Defensin hBD-1
JP3579549B2 (ja) * 1995-10-24 2004-10-20 株式会社トクヤマ 糖尿病または糖尿病合併症用マーカーとしての使用

Also Published As

Publication number Publication date
US6875616B1 (en) 2005-04-05
CZ49199A3 (cs) 2000-04-12
JP2001508864A (ja) 2001-07-03
CZ294729B6 (cs) 2005-03-16
CN1233326A (zh) 1999-10-27
WO1998007036A1 (de) 1998-02-19
AU4298897A (en) 1998-03-06
AU720626B2 (en) 2000-06-08
EP0922226B2 (de) 2008-06-25
CA2263443A1 (en) 1998-02-19
PL331612A1 (en) 1999-08-02
PL186810B1 (pl) 2004-02-27
DK0922226T3 (da) 2003-07-07
EP0922226A1 (de) 1999-06-16
ATE234469T1 (de) 2003-03-15
DE59709517D1 (de) 2003-04-17
EA199900196A1 (ru) 1999-06-24
EP0922226B1 (de) 2003-03-12
IS4971A (is) 1999-02-10
PT922226E (pt) 2003-07-31
EA001033B1 (ru) 2000-08-28
CA2263443C (en) 2004-03-30

Similar Documents

Publication Publication Date Title
ES2191175T3 (es) Procedimiento para la captacion del estado de un organismo por medicion de peptidos.
ATE268565T1 (de) Nicht-invasive messung von optisch-aktiven verbindungen
BR9611405A (pt) Processo e aparelho para obtenção de dados representativos do desempenho operacional de um dispositivo de controle de processo, sistema de controle para avaliação da operação de um dispositivo de controle utilizado para controlar um processo, e, processo para aquisição de dados.
EA200500056A1 (ru) Устройство, система и способ сбора геофизических данных
DE69404648D1 (de) Empfindlichkeitsprüfungsvorrichtung für rauchdetektor
ATE321340T1 (de) Ultrasensitive überwachung von sensoren und prozessen
DE60225669D1 (de) Erlumina
ES2181183T3 (es) Dispositivo y procedimiento para la deteccion de un objeto en un ambito de espacio determinado, especialmente de vehiculos para la supervision de trafico.
DE69912899D1 (de) Blutgerinnsel-Detektor
KR870004458A (ko) 감지기 신호 처리기 검사 방법 및 장치
BR8101641A (pt) Instalacao de teste para um sistema medidor de comprimento ou de angulo, digital, fotoeletrico
NO910771L (no) Dynamometrisk maaleinnretning for boreroer.
ATE312549T1 (de) Korrektur von blutdruckmessungen bei invasiven flüssigkeitsgefüllten systemen
ES2186121T3 (es) Mejora de los resultados de los dosificados de inmunodeteccion gracias al empleo de varios trazadores.
DE68914630D1 (de) System zum kalibrieren der ausgabeebene eines optischen korrelators.
GB2327136A (en) Coin testing apparatus and method
BR9712762B1 (pt) processo para testar a confiabilidade de um aparelho de teste, especialmente de um dispositivo para inspeção de garrafas vazias.
BR0015288A (pt) Método e aparelho para o teste de um sensor
DE59006602D1 (de) Sensorsystem.
JPS5212881A (en) Device for measuring a degree of deflection of fluorescence
NO172612C (no) Fremgangsmaate ved radiolokalisering av et fartoey som baerer en mottakingsanordning, ved maaling av forskjellene mellom tidspunktene for mottaking av radiofrekvenssignaler, og en mottakingsanordning for utfoerelse av fremgangsmaaten
BR8903382A (pt) Sensor,aparelho detector de pressao fluidica; regulador de pressao de gas; dispositivo medidor de desiocamento; dispositivo sensor de forca
JPS542184A (en) Plane bending fatigue tester
UA26902C2 (uk) Спосіб перевірки ступеhя точhості або hадійhості засобів вимірюваhhя і пристрій для його здійсhеhhя
ES2070744B1 (es) Procedimiento y equipo para reconocimiento y analisis de los efectos de un proceso reproducible sobre una o varias magnitudes que se observan en el espacio y en el tiempo.